Clinical Trial Update: Vitamin E Dosing Study [Phase 2]

View source ↗

Summary

A Phase II trial evaluating different dosing regimens of vitamin E for nonalcoholic fatty liver disease and nonalcoholic steatohepatitis has completed and poste…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonalcoholic Fatty Liver Disease
• Nonalcoholic Steatohepatitis

Drugs mentioned

• Vitamin E (tocopherol)

Snippet

Sponsor: National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Conditions: Nonalcoholic Fatty Liver Disease, Nonalcoholic Steatohepatitis | Phase 2 | Status: COMPLETED | Results posted: 2026-03-25